BALAXI Financial Statements

Balaxi Pharmaceuticals Profit & Loss Statement

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2019 -
Growth matrix (%)        
Revenue growth 407 236 -- --
Op profit growth 599 290 -- --
EBIT growth 400 264 -- --
Net profit growth 525 210 -- --
Profitability ratios (%)        
OPM 18.30 13.30 11.40 --
EBIT margin 19.20 19.40 17.90 --
Net profit margin 16.50 13.40 14.50 --
RoCE 92 56.80 -- --
RoNW 20.60 9.76 -- --
RoA 19.80 9.77 -- --
Per share ratios ()        
EPS 38.10 6.10 6.47 --
Dividend per share -- -- -- --
Cash EPS 37.80 6.10 6.46 --
Book value per share 65 27.80 11.60 --
Valuation ratios        
P/E 13.80 12.10 5.87 --
P/CEPS 13.90 12.10 5.89 --
P/B 8.07 2.67 3.28 --
EV/EBIDTA 11.80 7.88 4.67 --
Payout (%)        
Dividend payout -- -- -- --
Tax payout (14) (31) (19) --
Liquidity ratios        
Debtor days 84 141 -- --
Inventory days 11.40 3.32 -- --
Creditor days (30) (36) -- --
Leverage ratios        
Interest coverage (3,385) -- -- --
Net debt / equity 0.03 (0.10) -- --
Net debt / op. profit 0.05 (0.70) (0.10) --
Cost breakup ()        
Material costs (74) (74) (75) --
Employee costs (3.70) (4.60) (6.60) --
Other costs (3.60) (8.50) (6.60) --
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2021 Mar-2020 Mar-2019 -
Revenue 231 45.60 13.60 --
yoy growth (%) 407 236 -- --
Raw materials (172) (34) (10) --
As % of sales 74.40 73.60 75.30 --
Employee costs (8.50) (2.10) (0.90) --
As % of sales 3.66 4.60 6.63 --
Other costs (8.30) (3.90) (0.90) --
As % of sales 3.59 8.52 6.63 --
Operating profit 42.40 6.07 1.56 --
OPM 18.30 13.30 11.40 --
Depreciation (0.30) -- -- --
Interest expense -- -- -- --
Other income 2.23 2.81 0.89 --
Profit before tax 44.30 8.87 2.44 --
Taxes (6.20) (2.80) (0.50) --
Tax rate (14) (31) (19) --
Minorities and other -- -- -- --
Adj. profit 38.10 6.10 1.97 --
Exceptional items -- -- -- --
Net profit 38.10 6.10 1.97 --
yoy growth (%) 525 210 -- --
NPM 16.50 13.40 14.50 --
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2019 -
Profit before tax 44.30 8.87 2.44 --
Depreciation (0.30) -- -- --
Tax paid (6.20) (2.80) (0.50) --
Working capital 59.60 -- -- --
Other operating items -- -- -- --
Operating cashflow 97.40 6.10 -- --
Capital expenditure 2.73 -- -- --
Free cash flow 100 6.10 -- --
Equity raised 24.30 29.40 -- --
Investments 3.42 -- -- --
Debt financing/disposal 3.66 -- -- --
Dividends paid -- -- -- --
Other items -- -- -- --
Net in cash 131 35.50 -- --
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2019 -
Equity capital 10 10 3.04 --
Preference capital -- -- -- --
Reserves 55 17.80 0.48 --
Net worth 65 27.80 3.52 --
Minority interest
Debt 3.66 -- -- --
Deferred tax liabilities (net) 0.01 -- -- --
Total liabilities 68.70 27.80 3.52 --
Fixed assets 2.45 0.19 0.01 --
Intangible assets
Investments 3.42 -- -- --
Deferred tax asset (net) -- -- -- --
Net working capital 61.10 23.50 3.37 --
Inventories 13.60 0.83 -- --
Inventory Days 21.50 6.64 -- --
Sundry debtors 76.80 29.70 5.47 --
Debtor days 121 238 147 --
Other current assets 1.77 1.23 0.49 --
Sundry creditors (25) (5.70) (2.10) --
Creditor days 39.30 45.80 55.80 --
Other current liabilities (6.20) (2.50) (0.50) --
Cash 1.67 4 0.13 --
Total assets 68.70 27.70 3.51 --
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Mar-2022 Dec-2021 Sep-2021 Jun-2021 Mar-2021
Gross Sales 89.10 61.70 70.20 58.30 53
Excise Duty -- -- -- -- --
Net Sales 89.10 61.70 70.20 58.30 53
Other Operating Income -- -- -- -- --
Other Income 4.07 (0.40) 0.13 1.17 (0.30)
Total Income 93.20 61.30 70.40 59.50 52.70
Total Expenditure ** 77.90 48.20 56.20 47 42.60
PBIDT 15.30 13.20 14.20 12.60 10
Interest 0.10 0.02 0.01 -- --
PBDT 15.20 13.10 14.20 12.60 10
Depreciation 0.17 0.16 0.12 0.07 0.06
Minority Interest Before NP -- -- -- -- --
Tax 2.30 0.80 1.96 1.78 1.61
Deferred Tax 0.01 -- 0.02 -- --
Reported Profit After Tax 12.70 12.20 12.10 10.70 8.36
Minority Interest After NP -- -- -- -- --
Net Profit after Minority Interest 12.70 12.20 12.10 10.70 8.36
Extra-ordinary Items -- -- -- -- --
Adjusted Profit After Extra-ordinary item 12.70 12.20 12.10 10.70 8.36
EPS (Unit Curr.) 12.70 12.20 12.10 10.70 8.36
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) -- -- -- -- --
Equity 10 10 10 10 10
Public Shareholding (Number) -- -- -- -- --
Public Shareholding (%) -- -- -- -- --
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- -- --
Non Encumbered - % in Total Promoters Holding -- -- -- -- --
Non Encumbered - % in Total Equity -- -- -- -- --
PBIDTM(%) 17.20 21.30 20.20 21.50 18.90
PBDTM(%) 17 21.30 20.10 21.50 18.90
PATM(%) 14.30 19.70 17.20 18.40 15.80
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity